Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -119,721 | -65,002 | 132,330 | -46,408 | -71,197 |
| Depreciation Amortization | 1,087 | -3,238 | 815 | 6,175 | 5,514 |
| Accounts receivable | 268 | 81,311 | -83,234 | 475 | 7,280 |
| Accounts payable and accrued liabilities | 1,017 | 2,392 | -962 | 1,992 | -60 |
| Other Working Capital | -33,632 | 30,262 | -68,532 | 20,471 | 3,294 |
| Other Operating Activity | 18,514 | -61,035 | 97,502 | 4,786 | 1,644 |
| Operating Cash Flow | $-132,467 | $-15,310 | $77,919 | $-12,509 | $-53,525 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,596 | -3,521 | -3,256 | -2,491 | -1,609 |
| Purchase Of Investment | -133,929 | -465,685 | -223,968 | -54,848 | -15,117 |
| Sale Of Investment | 261,971 | 374,347 | 85,581 | 50,000 | 82,632 |
| Investing Cash Flow | $125,446 | $-94,859 | $-141,643 | $-7,339 | $65,906 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 816 | 114,015 | 33,645 | 1,110 | 612 |
| Financing Cash Flow | $816 | $114,015 | $33,645 | $1,110 | $612 |
| Beginning Cash Position | 74,241 | 70,395 | 100,474 | 119,212 | 106,219 |
| End Cash Position | 68,036 | 74,241 | 70,395 | 100,474 | 119,212 |
| Net Cash Flow | $-6,205 | $3,846 | $-30,079 | $-18,738 | $12,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,467 | -15,310 | 77,919 | -12,509 | -53,525 |
| Capital Expenditure | -2,596 | -3,521 | -3,256 | -2,491 | -1,609 |
| Free Cash Flow | -135,063 | -18,831 | 74,663 | -15,000 | -55,134 |